-
1
-
-
0000613769
-
Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion
-
K. Tatemoto Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion Proc Natl Acad Sci USA 79 1982 2514 2518
-
(1982)
Proc Natl Acad Sci USA
, vol.79
, pp. 2514-2518
-
-
Tatemoto, K.1
-
2
-
-
0345405976
-
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility
-
J.M. Lundberg, K. Tatemoto, L. Terenius Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility Pro Natl Acad Sci USA 79 1982 4471 4475
-
(1982)
Pro Natl Acad Sci USA
, vol.79
, pp. 4471-4475
-
-
Lundberg, J.M.1
Tatemoto, K.2
Terenius, L.3
-
3
-
-
0027463425
-
Effects of peptide YY on the growth of the pancreas and intestine
-
D. Guan, N. Rivard, J. Morisset, G.H. Greeley Jr Effects of peptide YY on the growth of the pancreas and intestine Endocrinology 132 1993 219 223
-
(1993)
Endocrinology
, vol.132
, pp. 219-223
-
-
Guan, D.1
Rivard, N.2
Morisset, J.3
Greeley Jr., G.H.4
-
4
-
-
0027482431
-
Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo
-
A.J. Bilchik, O.J. Hines, T.E. Adrian Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo Gastroenterology 105 1993 1441 1448
-
(1993)
Gastroenterology
, vol.105
, pp. 1441-1448
-
-
Bilchik, A.J.1
Hines, O.J.2
Adrian, T.E.3
-
5
-
-
0027185553
-
Peptide YY ameliorates cerulein-induced pancreatic injury in the rat
-
J.M. Tito, M. Rudnicki, D.H. Jones Peptide YY ameliorates cerulein-induced pancreatic injury in the rat Am J Surg 165 1993 690 696
-
(1993)
Am J Surg
, vol.165
, pp. 690-696
-
-
Tito, J.M.1
Rudnicki, M.2
Jones, D.H.3
-
6
-
-
0028830714
-
Intestinal peptide YY: Ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel
-
G. Gomez, T. Zhang, S. Rajaraman Intestinal peptide YY: Ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel Am J Physiol 268 1995 G71 81
-
(1995)
Am J Physiol
, vol.268
-
-
Gomez, G.1
Zhang, T.2
Rajaraman, S.3
-
7
-
-
0029095874
-
Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels
-
C.D. Liu, L.W. Slice, A. Balasubramaniam Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels Surgery 118 1995 229 235
-
(1995)
Surgery
, vol.118
, pp. 229-235
-
-
Liu, C.D.1
Slice, L.W.2
Balasubramaniam, A.3
-
8
-
-
0036135229
-
Peptide YY improves local and systemic parameters and prevents death in lethal necrotizing pancreatitis
-
K.R. Grise, D.W. McFadden Peptide YY improves local and systemic parameters and prevents death in lethal necrotizing pancreatitis Pancreas 24 2002 90 95
-
(2002)
Pancreas
, vol.24
, pp. 90-95
-
-
Grise, K.R.1
McFadden, D.W.2
-
9
-
-
0042290350
-
Peptide YY suppresses serum IL-6 and TNF-alpha levels in a murine model of acute pancreatitis
-
K. Reed, D. McFadden Peptide YY suppresses serum IL-6 and TNF-alpha levels in a murine model of acute pancreatitis Surgical Forum 48 1997 179 180
-
(1997)
Surgical Forum
, vol.48
, pp. 179-180
-
-
Reed, K.1
McFadden, D.2
-
10
-
-
0042733756
-
Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro
-
K.K. Kazanjian, S. Towfigh, D.W. McFadden Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro J Surg Res 114 2003 95 99
-
(2003)
J Surg Res
, vol.114
, pp. 95-99
-
-
Kazanjian, K.K.1
Towfigh, S.2
McFadden, D.W.3
-
11
-
-
0029055372
-
Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1
-
C.D. Liu, A. Balasubramaniam, R.E. Saxton Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 J Surg Res 58 1995 707 712
-
(1995)
J Surg Res
, vol.58
, pp. 707-712
-
-
Liu, C.D.1
Balasubramaniam, A.2
Saxton, R.E.3
-
12
-
-
0030050840
-
Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth
-
C.D. Liu, A.J. Rongione, L. Garvey Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth Am J Surg 171 1996 192 196
-
(1996)
Am J Surg
, vol.171
, pp. 192-196
-
-
Liu, C.D.1
Rongione, A.J.2
Garvey, L.3
-
13
-
-
0035294402
-
Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells
-
C.D. Liu, D. Kwan, N. Simon, D.W. McFadden Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells J Gastrointest Surg 5 2001 147 152
-
(2001)
J Gastrointest Surg
, vol.5
, pp. 147-152
-
-
Liu, C.D.1
Kwan, D.2
Simon, N.3
McFadden, D.W.4
-
14
-
-
0032816580
-
Peptide YY inhibits growth of human breast cancer in vitro and in vivo
-
K.R. Grise, A.J. Rongione, E.C. Laird, D.W. McFadden Peptide YY inhibits growth of human breast cancer in vitro and in vivo J Surg Res 82 1999 151 155
-
(1999)
J Surg Res
, vol.82
, pp. 151-155
-
-
Grise, K.R.1
Rongione, A.J.2
Laird, E.C.3
McFadden, D.W.4
-
15
-
-
0034214310
-
Peptide YY and vitamin e inhibit hormone-sensitive and -insensitive breast cancer cells
-
T. Heisler, S. Towfigh, N. Simon, D.W. McFadden Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells J Surg Res 91 2000 9 14
-
(2000)
J Surg Res
, vol.91
, pp. 9-14
-
-
Heisler, T.1
Towfigh, S.2
Simon, N.3
McFadden, D.W.4
-
16
-
-
0036290199
-
Vitamin e and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor
-
A. Yu, P. Somasundar, A. Balasubramaniam Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor J Surg Res 105 2002 65 68
-
(2002)
J Surg Res
, vol.105
, pp. 65-68
-
-
Yu, A.1
Somasundar, P.2
Balasubramaniam, A.3
-
17
-
-
1542268360
-
A target for prevention and treatment of esophageal cancer
-
N. Altorki A target for prevention and treatment of esophageal cancer J Surg Res 117 2004 114 120
-
(2004)
J Surg Res
, vol.117
, pp. 114-120
-
-
Altorki, N.1
-
18
-
-
0242361291
-
Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma
-
D.W. McFadden, D.R. Riggs, B.J. Jackson, L. Vona-Davis Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma Am J Surg 186 2003 552 555
-
(2003)
Am J Surg
, vol.186
, pp. 552-555
-
-
McFadden, D.W.1
Riggs, D.R.2
Jackson, B.J.3
Vona-Davis, L.4
-
19
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
T. Mosmann Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55 63
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
20
-
-
0032437922
-
Multiple comparison procedures updated
-
J. Ludbrook Multiple comparison procedures updated Clin Exp Pharmacol Physiol 25 1998 1032 1037
-
(1998)
Clin Exp Pharmacol Physiol
, vol.25
, pp. 1032-1037
-
-
Ludbrook, J.1
-
21
-
-
0032533670
-
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
-
S.S. Devesa, W.J. Blot, J.F. Fraumeni Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 1998 2049 2053
-
(1998)
Cancer
, vol.83
, pp. 2049-2053
-
-
Devesa, S.S.1
Blot, W.J.2
Fraumeni Jr., J.F.3
-
22
-
-
17944386992
-
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
-
W.H. Chow, W.J. Blot, T.L. Vaughan Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia J Natl Cancer Inst 90 1998 150 155
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 150-155
-
-
Chow, W.H.1
Blot, W.J.2
Vaughan, T.L.3
-
23
-
-
0036161377
-
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
-
R.F. Souza, K. Shewmake, L.S. Terada, S.J. Spechler Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus Gastroenterology 122 2002 299 307
-
(2002)
Gastroenterology
, vol.122
, pp. 299-307
-
-
Souza, R.F.1
Shewmake, K.2
Terada, L.S.3
Spechler, S.J.4
-
24
-
-
0033969552
-
Peptide YY augments gross inhibition by vitamin e succinate of human pancreatic cancer cell growth
-
T. Heisler, S. Towfigh, N. Simon Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth J Surg Res 88 2000 23 25
-
(2000)
J Surg Res
, vol.88
, pp. 23-25
-
-
Heisler, T.1
Towfigh, S.2
Simon, N.3
-
25
-
-
0033429336
-
B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer
-
K. Kling, F. Kim, M. Cole, D. McFadden B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer Am J Surg 178 1999 411 414
-
(1999)
Am J Surg
, vol.178
, pp. 411-414
-
-
Kling, K.1
Kim, F.2
Cole, M.3
McFadden, D.4
-
26
-
-
0344440976
-
Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma
-
S.H. Doak, G.J. Jenkins, E.M. Parry Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma Br J Cancer 89 2003 1729 1735
-
(2003)
Br J Cancer
, vol.89
, pp. 1729-1735
-
-
Doak, S.H.1
Jenkins, G.J.2
Parry, E.M.3
-
27
-
-
0036159620
-
Peptide YY and cancer: Current findings and potential clinical applications
-
W.W. Tseng, C.D. Liu Peptide YY and cancer: Current findings and potential clinical applications Peptides 23 2002 389 395
-
(2002)
Peptides
, vol.23
, pp. 389-395
-
-
Tseng, W.W.1
Liu, C.D.2
-
28
-
-
0034667497
-
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells
-
R.F. Souza, K. Shewmake, D.G. Beer Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells Cancer Res 60 2000 5756 5772
-
(2000)
Cancer Res
, vol.60
, pp. 5756-5772
-
-
Souza, R.F.1
Shewmake, K.2
Beer, D.G.3
-
29
-
-
0037953174
-
Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation
-
A.A. Raouf, D.A. Evoy, E. Carton Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation Dis Esophagus 16 2003 17 23
-
(2003)
Dis Esophagus
, vol.16
, pp. 17-23
-
-
Raouf, A.A.1
Evoy, D.A.2
Carton, E.3
|